NASH and Liver Disease Capabilities

Nonalcoholic Fatty Liver Diseases & Non-alcoholic Steatohepatitis (NAFLD & NASH)

As a leading laboratory services organization for trials across the globe, we integrate therapeutic insights, state-of-the-art technologies, best-in-class methods and quality systems to optimize your NAFLD or NASH study design, assuring high-quality data delivery and regulatory approval. Our network of laboratories offer services across the globe including anatomic pathology and biomarker delivery. 

Download our fact sheet to learn about our capabilities supporting NASH and liver disease clinical trials.

Related Services:

Global Clinical Trial Laboratory Services

Q2 Solutions Company Overview

Q2 Solutions Company Brochure

Learn about what we do and our commitment to innovation

Q2 Solutions Genomic Laboratory Services

Genomic Know-How® for your drug development needs

Read More